4//SEC Filing
ICAGEN INC 4
Accession 0001209191-11-046935
CIK 0000902622operating
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 4:46 PM ET
Size
4.9 KB
Accession
0001209191-11-046935
Insider Transaction Report
Form 4
ICAGEN INCICGN
Katz Richard D
Ex VP, Fin & Corp, CFO & Treas
Transactions
- Disposition from Tender
Common Stock
2011-09-02$6.00/sh−25,034$150,204→ 50,938 total
Footnotes (1)
- [F1]The reported transaction represents 25,034 shares of common stock tendered to Eclipse Acquisition Corp. ("Purchaser"), a wholly-owned subsidiary of Pfizer Inc. ("Pfizer"), pursuant to Purchaser's offer to purchase all of the issued and outstanding shares of common stock of Issuer at a price per share of $6.00, net to the holder thereof in cash, without interest thereon, less any applicable withholding and transfer taxes, upon the terms and subject to the conditions set forth in the Offer to Purchase for Cash, filed with the SEC by Pfizer and Purchaser on August 3, 2011, as amended (the "Tender Offer").
Documents
Issuer
ICAGEN INC
CIK 0000902622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000902622
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 4:46 PM ET
- Size
- 4.9 KB